OrbiMed Israel BioFund GP Limited Partnership 13D and 13G filings for INNOVATE BIOPHARMACEUTICALS IN:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-01 5:20 pm Sale | 2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% | -3,027,545 (-19.68%) | Filing |
| 2021-06-28 5:24 pm Sale | 2021-06-24 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6.000% | -17,118,837 (-52.67%) | Filing |
| 2021-04-07 4:46 pm Unchanged | 2021-04-05 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.200% | 0 (Unchanged) | Filing |
| 2021-03-25 5:26 pm Unchanged | 2021-03-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.600% | 0 (Unchanged) | Filing |
| 2020-12-16 5:13 pm Purchase | 2020-12-15 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16.000% | 1,943,734 (+6.36%) | Filing |
| 2020-07-29 1:38 pm Unchanged | 2020-07-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 21.400% | 0 (Unchanged) | Filing |
| 2020-05-14 5:25 pm Purchase | 2020-05-04 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 27.300% | 30,559,521 (New Position) | Filing |